Expertise in
3
conditions

Chin-chung Y. Shu

Hsin Chu Branch, 
Hsinchu, TNQ, TW 
Expertise in
3
conditions
Hsin Chu Branch, 
Hsinchu, TNQ, TW 

Overview

Chin-chung Shu practices practicing medicine in Hsinchu, Taiwan.

Shu is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, Pulmonary Tuberculosis, Bronchiectasis, and Kidney Transplant.

They are actively involved in clinical research, co-authoring 120 peer reviewed articles and participating in 1 clinical trial.

Locations

Hsin Chu Branch, Hsinchu, TNQ, Taiwan
Other Locations
No. 7, Chung Shan South Road, TPQ 10002, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Evaluation of the Efficacy and Safety of a Short-course, Daily, 4-month Regimen Including Isoniazid, Pyrazinamide, Rifapentine and Moxifloxacin (2HZPM/2HPM) for the Treatment of Drug-susceptible Pulmonary Tuberculosis in Taiwan (ESCAPE-TB)
Evaluation of the Efficacy and Safety of a Short-course, Daily, 4-month Regimen Including Isoniazid, Pyrazinamide, Rifapentine and Moxifloxacin (2HZPM/2HPM) for the Treatment of Drug-susceptible Pulmonary Tuberculosis in Taiwan (ESCAPE-TB)
Enrollment Status: Unknown
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: 4-Month Rifapentine-Based Regimen
Study Phase: Phase 3

120 Total Publications

Effectiveness of mass spectrometry and genomic analysis in the surveillance of nontuberculous Mycobacterium in Taiwan.
Effectiveness of mass spectrometry and genomic analysis in the surveillance of nontuberculous Mycobacterium in Taiwan.
Journal: Journal of clinical microbiology
Published: August 14, 2026

Frequently Asked Questions about Chin-chung Y. Shu

Is Chin-chung Y. Shu a top-rated expert for Nontuberculous Mycobacterial Lung Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Chin-chung Y. Shu is classified as an Elite expert for Nontuberculous Mycobacterial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chin-chung Y. Shu participate in research or clinical trials?

Yes. Chin-chung Y. Shu has published 120 articles and abstracts on conditions like Nontuberculous Mycobacterial Lung Disease. You can view a list of Chin-chung Y. Shu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shu's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile